Cargando…

Leptomeningeal Metastases in Hormone Refractory Prostate Cancer

Leptomeningeal metastases from the prostate are extremely rare, with few cases described in the medical literature (antemortem prevalence of less than 0.03%). Prostatic leptomeningeal metastases harbour a poor prognosis with a median survival after diagnosis of 15.7 weeks. We present the case of an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Jessica Y, Ng, Justin Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2018
Materias:	Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997428/ https://www.ncbi.nlm.nih.gov/pubmed/29900090 http://dx.doi.org/10.7759/cureus.2470

Ejemplares similares

Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer
por: Delgado, Jessica, et al.
Publicado: (2022)

Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis
por: Kunath, Frank, et al.
Publicado: (2015)

Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer
por: Boyd, Kathleen A, et al.
Publicado: (2015)

TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment
por: van Elst, Tessa, et al.
Publicado: (2023)

Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer
por: Khan, Anwar, et al.
Publicado: (2023)

Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
por: Rojas-Manrique, Juan P, et al.
Publicado: (2019)

Disseminated Intravascular Coagulation With Excessive Fibrinolysis Following Diagnostic Prostatic Biopsy for Prostate Cancer
por: Ghallab, Muhammad, et al.
Publicado: (2022)

Prostate Cancer Support Groups: The Unadvertised Camaraderie
por: Santarelli, Shana, et al.
Publicado: (2021)

Using Google Trends and Twitter for Prostate Cancer Awareness: A Comparative Analysis of Prostate Cancer Awareness Month and Breast Cancer Awareness Month
por: Johnson, Bradley S, et al.
Publicado: (2021)

Characterization of Google Search Volumes and Trends From 2004 to 2021 for Diagnosis and Treatment of Locally Advanced Prostate Cancer
por: Kim, Jessica, et al.
Publicado: (2023)

A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design
por: Freedland, Stephen J, et al.
Publicado: (2021)

Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial
por: Nam, Robert, et al.
Publicado: (2022)

Systematic Review of Focal and Salvage Cryotherapy for Prostate Cancer
por: Chin, Yew Fung, et al.
Publicado: (2022)

Editorial Comment: Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer
por: Lott, Felipe
Publicado: (2020)

Assessing the safety and feasibility of neoadjuvant hormone and radiation therapy followed by robot-assisted radical prostatectomy for treating locally advanced prostate cancer: protocol for an open-label, dose-escalation, single-centre, phase I clinical trial
por: Xiao, Yu-Tian, et al.
Publicado: (2020)

Exophytic benign prostatic hyperplasia presenting with refractory retention: A rare entity
por: Khanna, Ashish, et al.
Publicado: (2018)

Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
por: Asif, Aqua, et al.
Publicado: (2023)

ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI
por: Marsden, Teresa, et al.
Publicado: (2021)

Treatment of Refractory Ischemic Priapism: A Case Report and Literature Review
por: Vazquez Gonzalez, Jose Rogelio, et al.
Publicado: (2023)

Antibody-Drug Conjugates in Prostate Cancer: A Systematic Review
por: Sardinha, Mariana, et al.
Publicado: (2023)

Exploring the Use of Artificial Intelligence and Robotics in Prostate Cancer Management
por: Arigbede, Olumide, et al.
Publicado: (2023)

Predicting prostate cancer progression: protocol for a retrospective cohort study to identify prognostic factors for prostate cancer outcomes using routine primary care data
por: Merriel, Samuel W D, et al.
Publicado: (2018)

Brain Metastases as Presenting Feature in 'Burned Out' Testicular Germ Cell Tumor
por: Johnson, Kate, et al.
Publicado: (2016)

Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
por: Beyer, Katharina, et al.
Publicado: (2022)

Efficacy of Degarelix in the Neoadjuvant Setting in Managing Locally Advanced Prostate Cancer
por: Sankaran, Sindhu, et al.
Publicado: (2023)

An Unusual Case of Metastatic Prostate Cancer Presenting as a Massive Urinoma
por: Dhawan, Vikas, et al.
Publicado: (2023)

Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer
por: Koie, Takuya, et al.
Publicado: (2020)

Acquired Bilateral Seminal Vesicle Cysts: A Rare Manifestation of Prostate Cancer
por: Abou Heidar, Nassib, et al.
Publicado: (2019)

Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol
por: Beyer, Katharina, et al.
Publicado: (2021)

Quality of Care for Prostate Cancer in Kashmir, India: A Real-World Study
por: Akhtar, Omar S, et al.
Publicado: (2023)

Current Trends in Incidence and Management of T1a and T1b Prostate Cancer
por: Khan, Firaas A, et al.
Publicado: (2023)

Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis
por: Zhao, Yi, et al.
Publicado: (2021)

Renal Cell Carcinoma Metastases to the Pancreas and the Thyroid Gland: A Case Report and Review of the Literature
por: Khiella, Marco, et al.
Publicado: (2018)

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
por: Nordström, Tobias, et al.
Publicado: (2019)

PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer
por: Tran, Vy, et al.
Publicado: (2022)

Prognostic Factors for Prostate Cancer Endpoints Following Biochemical Failure: A Review of the Literature
por: Nguyen, Tim, et al.
Publicado: (2015)

Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten-Year Analysis
por: Katz, Alan
Publicado: (2017)

Contemporary Management of Chronic Prostatitis
por: Khattak, Ahmed S, et al.
Publicado: (2021)

Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trial
por: Müllhaupt, Gautier, et al.
Publicado: (2021)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)
por: Drake, Marcus J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8m758k4uqc68g0pbmbcsi9po0o